Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.49 |
| ▸ | CTSK | P43235 | 7/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | CTSS | P25774 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13899365 | 0.89 | ATM (0.46) | ATMCTSLCTSSCTSB | |
| SCHEMBL13899543 | 0.89 | ATM (0.46) | ATMCTSLCTSS | |
| SCHEMBL13721611 | 0.87 | ATM (0.57) | ATMCTSLCTSSMEN1LMNA | |
| SCHEMBL12052784 | 0.79 | ITGB3 (0.67) | CTSKCTSLCTSSCTSB | |
| SCHEMBL1701856 | 0.79 | ITGB3 (0.67) | CTSKCTSLCTSSCTSB | |
| SCHEMBL14099875 | 0.76 | HSD17B10 (0.45) | CTSKATMCTSLCTSSCTSB | |
| SCHEMBL5106118 | 0.76 | HSD17B10 (0.45) | CTSKATMCTSLCTSSCTSB | |
| SCHEMBL29944699 | 0.76 | TP53 (0.50) | CTSKATMCTSLCTSSCTSB | |
| SCHEMBL29944721 | 0.76 | TP53 (0.50) | CTSKATMCTSLCTSSCTSB | |
| SCHEMBL1553867 | 0.75 | GPR88 (0.44) | AAK1ATMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7507757-B2 | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-03-24 | — | — | US | disclosed |